May 27, 2009 | CiteULike
Recovery of proximal tibia bone mineral density and strength, but not ...
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
Osteogenesis Imperfecta: Update on presentation and management
Traditionally OI was classified into OI types I to IV and thought to be only due to a defect in the collagen gene, however through the discovery of the new types of OIa 'V to VII, breakthroughs have been made in understanding the pathophysiology of autosomal recessive OI and new genetic mutations, such as in CRTAP and P3H1 genes.
True Stories: Serious complications of drugs for osteoporosis
Bones are formed, molded and absorbed continuously. Bone cells, called osteoblasts, are responsible for the new bone formation and cells known as osteoclasts absorb the bone.
New Concerns Regarding Use Of Bisphosphonates
Bisphosphonates are a class of drug that slow bone resorption by reducing osteoclast function.
Sun Pharma Receives USFDA Approvals For 4 Generic Products
Sun Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from USFDA for several Abbreviated New Drug Applications .
Arthritis Patients Should Be Aware of Complication Tied to Bisphosphonate Use
It's not uncommon for arthritis patients to be prescribed one of the bisphosphonates.
Sun Pharma gets USFDA nod for four generic drugs
Drug major Sun Pharmaceutical Industries today said the company, along with its subsidiary, has received abbreviated new drug application approval for four generic products from the US health regulator.
India's Sun Pharmaceutical Industries Ltd Gets FDA Nod for Four Generics
Sun Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from USFDA for several Abbreviated New Drug Applications .